216 related articles for article (PubMed ID: 8635676)
1. Inhibition of muscle glycogen synthase activity and non-oxidative glucose disposal during hypoglycaemia in normal man.
Orskov L; Bak JF; Abildgård ; Schmitz O; Andreasen F; Richter EA; Skjaerbaek C; Møller N
Diabetologia; 1996 Feb; 39(2):226-34. PubMed ID: 8635676
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle glucose uptake, glycogen synthase activity and GLUT 4 content during hypoglycaemia in type 1 diabetic subjects.
Orskov L; Schmitz O; Bak JF; Lund S; Kaal A; Nyholm B; Møller N
Scand J Clin Lab Invest; 2001; 61(5):371-81. PubMed ID: 11569484
[TBL] [Abstract][Full Text] [Related]
3. Forearm substrate exchange during hyperinsulinaemic hypoglycaemia in normal man.
Abildgaard N; Orskov L; Petersen JA; Alberti KG; Schmitz O; Møller N
Diabet Med; 1995 Mar; 12(3):218-23. PubMed ID: 7758257
[TBL] [Abstract][Full Text] [Related]
4. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man.
Ebeling P; Koivisto VA
Diabetologia; 1994 Feb; 37(2):202-9. PubMed ID: 8163056
[TBL] [Abstract][Full Text] [Related]
5. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
[TBL] [Abstract][Full Text] [Related]
6. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
7. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
Vestergaard H; Lund S; Bjørbaek C; Pedersen O
Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
[TBL] [Abstract][Full Text] [Related]
8. Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle.
Raz I; Katz A; Spencer MK
Am J Physiol; 1991 Mar; 260(3 Pt 1):E430-5. PubMed ID: 1900669
[TBL] [Abstract][Full Text] [Related]
9. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
[TBL] [Abstract][Full Text] [Related]
11. Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
Suh KI; Murata C; Song YM; Joyce M; Gumbiner B; Ditzler TM; Henry RR
J Clin Endocrinol Metab; 1993 Aug; 77(2):464-70. PubMed ID: 8345053
[TBL] [Abstract][Full Text] [Related]
12. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
Bak JF; Møller N; Schmitz O; Saaek A; Pedersen O
Diabetologia; 1992 Aug; 35(8):777-84. PubMed ID: 1511806
[TBL] [Abstract][Full Text] [Related]
13. Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine.
Dagogo-Jack S; Askari H; Morrill B; Lehner LL; Kim B; Sha X
Diabetes Obes Metab; 2000 Dec; 2(6):373-83. PubMed ID: 11225967
[TBL] [Abstract][Full Text] [Related]
14. Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans.
Laurent D; Petersen KF; Russell RR; Cline GW; Shulman GI
Am J Physiol; 1998 Jan; 274(1):E130-8. PubMed ID: 9458758
[TBL] [Abstract][Full Text] [Related]
15. Progressive defect of insulin action on glycogen synthase in obesity and diabetes.
Golay A; Munger R; Assimacopoulos-Jeannet F; Bobbioni-Harsch E; Habicht F; Felber JP
Metabolism; 2002 May; 51(5):549-53. PubMed ID: 11979384
[TBL] [Abstract][Full Text] [Related]
16. Neonatal de-afferentation of capsaicin-sensitive sensory nerves increases in vivo insulin sensitivity in conscious adult rats.
Koopmans SJ; Leighton B; DeFronzo RA
Diabetologia; 1998 Jul; 41(7):813-20. PubMed ID: 9686923
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity.
Ebeling P; Bourey R; Koranyi L; Tuominen JA; Groop LC; Henriksson J; Mueckler M; Sovijärvi A; Koivisto VA
J Clin Invest; 1993 Oct; 92(4):1623-31. PubMed ID: 8408617
[TBL] [Abstract][Full Text] [Related]
18. Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man.
Johnson AB; Argyraki M; Thow JC; Cooper BG; Fulcher G; Taylor R
Clin Sci (Lond); 1992 Feb; 82(2):219-26. PubMed ID: 1311661
[TBL] [Abstract][Full Text] [Related]
19. Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletion.
Tuominen JA; Ebeling P; Vuorinen-Markkola H; Koivisto VA
Diabet Med; 1997 Apr; 14(4):301-8. PubMed ID: 9113484
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.
Vaag A; Damsbo P; Hother-Nielsen O; Beck-Nielsen H
Diabetologia; 1992 Jan; 35(1):80-8. PubMed ID: 1541385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
